These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

225 related items for PubMed ID: 9396468

  • 1. Impaired nitric oxide-mediated renal vasodilation in rats with experimental heart failure: role of angiotensin II.
    Abassi ZA, Gurbanov K, Mulroney SE, Potlog C, Opgenorth TJ, Hoffman A, Haramati A, Winaver J.
    Circulation; 1997 Nov 18; 96(10):3655-64. PubMed ID: 9396468
    [Abstract] [Full Text] [Related]

  • 2. Support of renal blood flow after ischaemic-reperfusion injury by endogenous formation of nitric oxide and of cyclo-oxygenase vasodilator metabolites.
    Cristol JP, Thiemermann C, Mitchell JA, Walder C, Vane JR.
    Br J Pharmacol; 1993 May 18; 109(1):188-94. PubMed ID: 7684301
    [Abstract] [Full Text] [Related]

  • 3. Renal hemodynamic responses to intrarenal infusion of acetylcholine: comparison with effects of PGE2 and NO donor.
    Badzyńska B, Sadowski J.
    Kidney Int; 2006 May 18; 69(10):1774-9. PubMed ID: 16572111
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Nitric oxide-dependent renal vasodilatation is not altered in rat with rHuEpo-induced hypertension.
    Migliori M, Taccola D, Panichi V, De Pietro S, Andreini B, Di Benedetto A, Filippi C, Palla R, Giovannini L.
    Kidney Blood Press Res; 1999 May 18; 22(3):140-5. PubMed ID: 10394113
    [Abstract] [Full Text] [Related]

  • 6. Renal ischemia-reperfusion injury: contribution of nitric oxide and renal blood flow.
    Mashiach E, Sela S, Winaver J, Shasha SM, Kristal B.
    Nephron; 1998 Dec 18; 80(4):458-67. PubMed ID: 9832646
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Elevation of an endogenous inhibitor of nitric oxide synthesis in experimental congestive heart failure.
    Feng Q, Lu X, Fortin AJ, Pettersson A, Hedner T, Kline RL, Arnold JM.
    Cardiovasc Res; 1998 Mar 18; 37(3):667-75. PubMed ID: 9659450
    [Abstract] [Full Text] [Related]

  • 9. The Role of Renal Vascular Reactivity in the Development of Renal Dysfunction in Compensated and Decompensated Congestive Heart Failure.
    Kratky V, Kopkan L, Kikerlova S, Huskova Z, Taborsky M, Sadowski J, Kolar F, Cervenka L.
    Kidney Blood Press Res; 2018 Mar 18; 43(6):1730-1741. PubMed ID: 30472713
    [Abstract] [Full Text] [Related]

  • 10. Role of Nitric oxide in the renal and systemic vasodilatory responses to platelet-activating factor in the rat, in vivo.
    Handa RK, Strandhoy JW, Handa SE.
    Kidney Blood Press Res; 2003 Mar 18; 26(3):165-75. PubMed ID: 12886044
    [Abstract] [Full Text] [Related]

  • 11. Renal vasodilatory effect of endothelial stimulation in patients with chronic congestive heart failure.
    Elkayam U, Cohen G, Gogia H, Mehra A, Johnson JV, Chandraratna PA.
    J Am Coll Cardiol; 1996 Jul 18; 28(1):176-82. PubMed ID: 8752811
    [Abstract] [Full Text] [Related]

  • 12. Cholesterol feeding does not alter renal hemodynamic response to acetylcholine and angiotensin II in rabbits.
    Carroll JF, Mizelle HL, Cockrell K, Reckelhoff JF, Clower BR, Granger JP.
    Am J Physiol; 1997 Mar 18; 272(3 Pt 2):R940-7. PubMed ID: 9087658
    [Abstract] [Full Text] [Related]

  • 13. Simvastatin reverses impaired regulation of renal oxygen consumption in congestive heart failure.
    Adler S, Huang H, Trochu JN, Xu X, Gupta S, Hintze TH.
    Am J Physiol Renal Physiol; 2001 Nov 18; 281(5):F802-9. PubMed ID: 11592937
    [Abstract] [Full Text] [Related]

  • 14. Regulation of intrarenal blood flow in experimental heart failure: role of endothelin and nitric oxide.
    Abassi Z, Gurbanov K, Rubinstein I, Better OS, Hoffman A, Winaver J.
    Am J Physiol; 1998 Apr 18; 274(4):F766-74. PubMed ID: 9575902
    [Abstract] [Full Text] [Related]

  • 15. Effects of connexin-mimetic peptides on nitric oxide synthase- and cyclooxygenase-independent renal vasodilation.
    De Vriese AS, Van de Voorde J, Lameire NH.
    Kidney Int; 2002 Jan 18; 61(1):177-85. PubMed ID: 11786099
    [Abstract] [Full Text] [Related]

  • 16. Losartan attenuates modest but not strong renal vasoconstriction induced by nitric oxide inhibition.
    Turkstra E, Braam B, Koomans HA.
    J Cardiovasc Pharmacol; 1998 Oct 18; 32(4):593-600. PubMed ID: 9781927
    [Abstract] [Full Text] [Related]

  • 17. Expression of constitutive and inducible nitric oxide synthases in the vascular wall of young and aging rats.
    Cernadas MR, Sánchez de Miguel L, García-Durán M, González-Fernández F, Millás I, Montón M, Rodrigo J, Rico L, Fernández P, de Frutos T, Rodríguez-Feo JA, Guerra J, Caramelo C, Casado S, López-Farré.
    Circ Res; 1998 Aug 10; 83(3):279-86. PubMed ID: 9710120
    [Abstract] [Full Text] [Related]

  • 18. Tetrahydrobiopterin improves impaired endothelium-dependent forearm vasodilation in patients with heart failure.
    Setoguchi S, Hirooka Y, Eshima K, Shimokawa H, Takeshita A.
    J Cardiovasc Pharmacol; 2002 Mar 10; 39(3):363-8. PubMed ID: 11862115
    [Abstract] [Full Text] [Related]

  • 19. Effects of eprosartan on renal function and cardiac hypertrophy in rats with experimental heart failure.
    Brodsky S, Gurbanov K, Abassi Z, Hoffman A, Ruffolo RR, Feuerstein GZ, Winaver J.
    Hypertension; 1998 Oct 10; 32(4):746-52. PubMed ID: 9774374
    [Abstract] [Full Text] [Related]

  • 20. Increased nitric oxide synthase activity despite lack of response to endothelium-dependent vasodilators in postischemic acute renal failure in rats.
    Conger J, Robinette J, Villar A, Raij L, Shultz P.
    J Clin Invest; 1995 Jul 10; 96(1):631-8. PubMed ID: 7542287
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 12.